Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells.
Patients suffering from heart failure as a result of myocardial infarction are in need of heart transplantation. Unfortunately the number of donor hearts is very low and therefore new therapies are subject of investigation. Cell transplantation therapy upon myocardial infarction is a very promising strategy to replace the dead myocardium with viable cardiomyocytes, smooth muscle cells and endothelial cells, thereby reducing scarring and improving cardiac performance. Despite promising results, resulting in reduced infarct size and improved cardiac function on short term, only a few cells survive the ischemic milieu and are retained in the heart, thereby minimizing long-term effects. Although new capillaries and cardiomyocytes are formed around the infarcted area, only a small percentage of the transplanted cells can be detected months after myocardial infarction. This suggests the stimulation of an endogenous regenerative capacity of the heart upon cell transplantation, resulting from release of growth factor, cytokine and other paracrine molecules by the progenitor cells--the so-called paracrine hypothesis. Here, we focus on a relative new component of paracrine signalling, i.e. exosomes. We are interested in the release and function of exosomes derived from cardiac progenitor cells and studied their effects on the migratory capacity of endothelial cells.
Vrijsen
K R
KR
University Medical Center Utrecht, Laboratory of Experimental Cardiology, Utrecht, The Netherlands.
Sluijter
J P G
JP
Schuchardt
M W L
MW
van Balkom
B W M
BW
Noort
W A
WA
Chamuleau
S A J
SA
Doevendans
P A F M
PA
D051926:Basigin / Q000378:metabolism; D002465:Cell Movement / Q000187:drug effects; D017077:Culture Media, Conditioned / Q000494:pharmacology; D042783:Endothelial Cells / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D055354:Exosomes / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008954:Models, Biological; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D017077:Culture Media, Conditioned; D051926:Basigin; D020782:Matrix Metalloproteinases
Nat Rev Immunol. 2002 Aug;2(8):569-79
12154376
Nature. 2001 Apr 5;410(6829):701-5
11287958
Circulation. 2003 Feb 25;107(7):1024-32
12600917
Cell. 2006 Aug 25;126(4):663-76
16904174
Cardiovasc Res. 2005 Oct 1;68(1):136-43
15963479
Oncogene. 2004 Jan 29;23(4):956-63
14749763
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
18228490
Nat Cell Biol. 2007 Jun;9(6):654-9
17486113
Neth Heart J. 2009 May;17(5):199-207
19484156
FASEB J. 2006 Apr;20(6):661-9
16581974
Neth Heart J. 2008 May;16(5):163-9
18566670
J Cell Biochem. 2008 Dec 1;105(5):1211-8
18802920
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1726-35
18723770
Circ Res. 2010 Mar 19;106(5):971-80
20110532
Science. 1998 Nov 6;282(5391):1145-7
9804556
Stem Cell Res. 2010 May;4(3):214-22
20138817
Cancer Res. 2005 Apr 15;65(8):3193-9
15833850
Stem Cell Res. 2007 Nov;1(2):138-49
19383394
Arch Intern Med. 2007 May 28;167(10):989-97
17533201
Cardiovasc Res. 2009 Aug 1;83(3):527-35
19429921
J Clin Invest. 1999 May;103(9):1237-41
10225966
Nature. 2008 Feb 21;451(7181):937-42
18288183
Nat Protoc. 2009;4(2):232-43
19197267
Circ Res. 2008 Nov 21;103(11):1204-19
19028920
Stem Cells. 2007 Jan;25(1):236-44
16973829
Circulation. 2010 Jan 19;121(2):293-305
20048209
Stem Cell Res. 2007 Nov;1(2):129-37
19383393
Curr Opin Organ Transplant. 2009 Oct;14(5):560-5
19623073
FASEB J. 2007 May;21(7):1345-57
17284483
J Mol Cell Cardiol. 2010 Jun;48(6):1215-24
20064522